Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herling

Showing results (471-480 of 481) with videos related to

Pageof 49
Sort By:
Biorxiv : the Preprint Server for Biology|March 30, 2023
ANXA11 biomolecular condensates facilitate protein-lipid phase coupling on lysosomal membranesJonathon Nixon-Abell, Francesco S Ruggeri, Seema Qamar, et al.
Nature Communications|February 21, 2024
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignanciesMathieu Ferrari, Matteo Righi, Vania Baldan, et al.
Nature Communications|March 22, 2025
ANXA11 biomolecular condensates facilitate protein-lipid phase coupling on lysosomal membranesJonathon Nixon-Abell, Francesco S Ruggeri, Seema Qamar, et al.
Leukemia|August 15, 2017
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profilingE I Andersson, S Pützer, B Yadav, et al.
Haematologica|May 25, 2019
High activation of STAT5A drives peripheral T-cell lymphoma and leukemiaBarbara Maurer, Harini Nivarthi, Bettina Wingelhofer, et al.
The Journal of Clinical Investigation|April 15, 2024
Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemiaTobias Suske, Helena Sorger, Gabriele Manhart, et al.
Blood|December 10, 2020
Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signalingS Oberbeck, A Schrader, K Warner, et al.
Blood|April 9, 2020
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemiaAdalgisa Condoluci, Lodovico Terzi di Bergamo, Petra Langerbeins, et al.
EMBO Molecular Medicine|November 7, 2022
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphomaHelena Sorger, Saptaswa Dey, Pablo Augusto Vieyra-Garcia, et al.
The Journal of Clinical Investigation|December 12, 2017
Drug-perturbation-based stratification of blood cancerSascha Dietrich, Małgorzata Oleś, Junyan Lu, et al.
Pageof 49

Showing results (471-480 of 481) with videos related to

Sort By:
Pageof 49
Biorxiv : the Preprint Server for Biology|March 30, 2023
ANXA11 biomolecular condensates facilitate protein-lipid phase coupling on lysosomal membranesJonathon Nixon-Abell, Francesco S Ruggeri, Seema Qamar, et al.
Nature Communications|February 21, 2024
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignanciesMathieu Ferrari, Matteo Righi, Vania Baldan, et al.
Nature Communications|March 22, 2025
ANXA11 biomolecular condensates facilitate protein-lipid phase coupling on lysosomal membranesJonathon Nixon-Abell, Francesco S Ruggeri, Seema Qamar, et al.
Leukemia|August 15, 2017
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profilingE I Andersson, S Pützer, B Yadav, et al.
Haematologica|May 25, 2019
High activation of STAT5A drives peripheral T-cell lymphoma and leukemiaBarbara Maurer, Harini Nivarthi, Bettina Wingelhofer, et al.
The Journal of Clinical Investigation|April 15, 2024
Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemiaTobias Suske, Helena Sorger, Gabriele Manhart, et al.
Blood|December 10, 2020
Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signalingS Oberbeck, A Schrader, K Warner, et al.
Blood|April 9, 2020
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemiaAdalgisa Condoluci, Lodovico Terzi di Bergamo, Petra Langerbeins, et al.
EMBO Molecular Medicine|November 7, 2022
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphomaHelena Sorger, Saptaswa Dey, Pablo Augusto Vieyra-Garcia, et al.
The Journal of Clinical Investigation|December 12, 2017
Drug-perturbation-based stratification of blood cancerSascha Dietrich, Małgorzata Oleś, Junyan Lu, et al.
Pageof 49